nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—ABCB1—kidney cancer	0.0927	1	CbGaD
Imipramine—CYP3A7—Temsirolimus—kidney cancer	0.042	0.0723	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.042	0.0723	CbGbCtD
Imipramine—SLC22A3—Vincristine—kidney cancer	0.0385	0.0662	CbGbCtD
Imipramine—ORM1—Erlotinib—kidney cancer	0.0349	0.0601	CbGbCtD
Imipramine—SLC22A2—Vinblastine—kidney cancer	0.0232	0.0399	CbGbCtD
Imipramine—ABCB1—Temsirolimus—kidney cancer	0.0205	0.0353	CbGbCtD
Imipramine—KCNH2—Sunitinib—kidney cancer	0.0203	0.0349	CbGbCtD
Imipramine—HTR2C—Sorafenib—kidney cancer	0.0196	0.0338	CbGbCtD
Imipramine—CYP2D6—Temsirolimus—kidney cancer	0.0193	0.0332	CbGbCtD
Imipramine—CYP3A4—Everolimus—kidney cancer	0.0182	0.0313	CbGbCtD
Imipramine—CYP3A7—Paclitaxel—kidney cancer	0.0144	0.0248	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.0144	0.0248	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.0128	0.022	CbGbCtD
Imipramine—CYP3A7—Sorafenib—kidney cancer	0.0128	0.022	CbGbCtD
Imipramine—CYP3A7—Vincristine—kidney cancer	0.0124	0.0214	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.0124	0.0214	CbGbCtD
Imipramine—CYP1A2—Pazopanib—kidney cancer	0.0123	0.0212	CbGbCtD
Imipramine—CYP3A4—Temsirolimus—kidney cancer	0.0123	0.0211	CbGbCtD
Imipramine—CYP2B6—Sorafenib—kidney cancer	0.0122	0.021	CbGbCtD
Imipramine—ABCB1—Pazopanib—kidney cancer	0.0108	0.0185	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.0104	0.0178	CbGbCtD
Imipramine—CYP3A7—Sunitinib—kidney cancer	0.0104	0.0178	CbGbCtD
Imipramine—CYP2D6—Pazopanib—kidney cancer	0.0102	0.0175	CbGbCtD
Imipramine—ABCB1—Dactinomycin—kidney cancer	0.00986	0.0169	CbGbCtD
Imipramine—CYP1A2—Erlotinib—kidney cancer	0.00879	0.0151	CbGbCtD
Imipramine—ABCB1—Gemcitabine—kidney cancer	0.00779	0.0134	CbGbCtD
Imipramine—CYP2C19—Sorafenib—kidney cancer	0.00775	0.0133	CbGbCtD
Imipramine—ABCB1—Erlotinib—kidney cancer	0.00769	0.0132	CbGbCtD
Imipramine—CHRM3—ureter—kidney cancer	0.00761	0.143	CbGeAlD
Imipramine—CYP2B6—Doxorubicin—kidney cancer	0.0074	0.0127	CbGbCtD
Imipramine—CYP2D6—Erlotinib—kidney cancer	0.00725	0.0125	CbGbCtD
Imipramine—CYP1A2—Sorafenib—kidney cancer	0.00715	0.0123	CbGbCtD
Imipramine—ABCB1—Paclitaxel—kidney cancer	0.00704	0.0121	CbGbCtD
Imipramine—CYP3A4—Pazopanib—kidney cancer	0.00646	0.0111	CbGbCtD
Imipramine—ABCB1—Sorafenib—kidney cancer	0.00625	0.0108	CbGbCtD
Imipramine—ABCB1—Vinblastine—kidney cancer	0.00617	0.0106	CbGbCtD
Imipramine—ABCB1—Vincristine—kidney cancer	0.00607	0.0104	CbGbCtD
Imipramine—CYP2D6—Sorafenib—kidney cancer	0.00589	0.0101	CbGbCtD
Imipramine—CYP2D6—Vinblastine—kidney cancer	0.00582	0.01	CbGbCtD
Imipramine—SLC22A2—nephron—kidney cancer	0.00526	0.0989	CbGeAlD
Imipramine—ABCB1—Sunitinib—kidney cancer	0.00507	0.00871	CbGbCtD
Imipramine—CYP3A4—Erlotinib—kidney cancer	0.00461	0.00792	CbGbCtD
Imipramine—CYP3A4—Paclitaxel—kidney cancer	0.00422	0.00725	CbGbCtD
Imipramine—ABCB1—Doxorubicin—kidney cancer	0.00379	0.00652	CbGbCtD
Imipramine—CYP3A4—Sorafenib—kidney cancer	0.00375	0.00644	CbGbCtD
Imipramine—CYP3A4—Vinblastine—kidney cancer	0.0037	0.00636	CbGbCtD
Imipramine—CYP3A4—Vincristine—kidney cancer	0.00364	0.00625	CbGbCtD
Imipramine—CYP2D6—Doxorubicin—kidney cancer	0.00357	0.00615	CbGbCtD
Imipramine—CYP3A4—Sunitinib—kidney cancer	0.00304	0.00522	CbGbCtD
Imipramine—Olopatadine—S100A1—kidney cancer	0.00257	0.532	CrCbGaD
Imipramine—CYP2C19—urine—kidney cancer	0.0023	0.0432	CbGeAlD
Imipramine—CYP3A4—Doxorubicin—kidney cancer	0.00227	0.00391	CbGbCtD
Imipramine—CYP1A2—urine—kidney cancer	0.00188	0.0353	CbGeAlD
Imipramine—CYP2E1—urine—kidney cancer	0.00169	0.0317	CbGeAlD
Imipramine—HTR2A—urine—kidney cancer	0.00147	0.0276	CbGeAlD
Imipramine—KCND3—cortex of kidney—kidney cancer	0.00137	0.0257	CbGeAlD
Imipramine—CYP3A4—urine—kidney cancer	0.00136	0.0255	CbGeAlD
Imipramine—CYP2D6—urine—kidney cancer	0.00134	0.0251	CbGeAlD
Imipramine—KCND3—cardiac atrium—kidney cancer	0.0013	0.0244	CbGeAlD
Imipramine—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.00118	0.0221	CbGeAlD
Imipramine—SLC22A2—nephron tubule—kidney cancer	0.00114	0.0213	CbGeAlD
Imipramine—SLC22A2—renal system—kidney cancer	0.00103	0.0194	CbGeAlD
Imipramine—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.00101	0.0189	CbGeAlD
Imipramine—SLC22A2—kidney—kidney cancer	0.000998	0.0188	CbGeAlD
Imipramine—ADRA1B—renal system—kidney cancer	0.000988	0.0186	CbGeAlD
Imipramine—SLC22A2—cortex of kidney—kidney cancer	0.000972	0.0183	CbGeAlD
Imipramine—ADRA1B—kidney—kidney cancer	0.000955	0.018	CbGeAlD
Imipramine—SLC22A4—nephron tubule—kidney cancer	0.000842	0.0158	CbGeAlD
Imipramine—SLC22A4—renal system—kidney cancer	0.000766	0.0144	CbGeAlD
Imipramine—SLC22A4—kidney—kidney cancer	0.00074	0.0139	CbGeAlD
Imipramine—SLC22A1—renal system—kidney cancer	0.000729	0.0137	CbGeAlD
Imipramine—SLC22A4—cortex of kidney—kidney cancer	0.000721	0.0136	CbGeAlD
Imipramine—SLC22A1—kidney—kidney cancer	0.000705	0.0132	CbGeAlD
Imipramine—SLC22A3—renal system—kidney cancer	0.000697	0.0131	CbGeAlD
Imipramine—Dimetacrine—ACHE—kidney cancer	0.000683	0.141	CrCbGaD
Imipramine—SLC22A3—kidney—kidney cancer	0.000674	0.0127	CbGeAlD
Imipramine—SLC22A3—gonad—kidney cancer	0.000625	0.0117	CbGeAlD
Imipramine—CHRM3—renal system—kidney cancer	0.000605	0.0114	CbGeAlD
Imipramine—HTR1A—renal system—kidney cancer	0.000602	0.0113	CbGeAlD
Imipramine—CHRM3—kidney—kidney cancer	0.000585	0.011	CbGeAlD
Imipramine—HTR7—renal system—kidney cancer	0.000576	0.0108	CbGeAlD
Imipramine—HTR7—kidney—kidney cancer	0.000557	0.0105	CbGeAlD
Imipramine—ADRA1A—renal system—kidney cancer	0.000555	0.0104	CbGeAlD
Imipramine—KCNH2—renal system—kidney cancer	0.000536	0.0101	CbGeAlD
Imipramine—SLC6A2—gonad—kidney cancer	0.000536	0.0101	CbGeAlD
Imipramine—HTR7—gonad—kidney cancer	0.000516	0.0097	CbGeAlD
Imipramine—CYP2B6—nephron tubule—kidney cancer	0.000484	0.0091	CbGeAlD
Imipramine—KCNH2—cardiac atrium—kidney cancer	0.00048	0.00903	CbGeAlD
Imipramine—CYP1A2—renal system—kidney cancer	0.000459	0.00863	CbGeAlD
Imipramine—CYP2E1—nephron tubule—kidney cancer	0.000454	0.00854	CbGeAlD
Imipramine—CYP2B6—renal system—kidney cancer	0.00044	0.00827	CbGeAlD
Imipramine—CYP2B6—kidney—kidney cancer	0.000425	0.008	CbGeAlD
Imipramine—CYP2E1—renal system—kidney cancer	0.000413	0.00776	CbGeAlD
Imipramine—CYP2E1—kidney—kidney cancer	0.000399	0.0075	CbGeAlD
Imipramine—CYP2B6—gonad—kidney cancer	0.000395	0.00742	CbGeAlD
Imipramine—CYP2E1—cortex of kidney—kidney cancer	0.000389	0.00731	CbGeAlD
Imipramine—HTR2A—renal system—kidney cancer	0.000359	0.00675	CbGeAlD
Imipramine—HTR2A—kidney—kidney cancer	0.000347	0.00652	CbGeAlD
Imipramine—CYP3A4—renal system—kidney cancer	0.000332	0.00625	CbGeAlD
Imipramine—CYP2D6—renal system—kidney cancer	0.000327	0.00615	CbGeAlD
Imipramine—HTR2A—gonad—kidney cancer	0.000322	0.00605	CbGeAlD
Imipramine—CYP3A4—kidney—kidney cancer	0.000321	0.00604	CbGeAlD
Imipramine—CYP2D6—kidney—kidney cancer	0.000316	0.00594	CbGeAlD
Imipramine—ABCB1—nephron tubule—kidney cancer	0.000259	0.00486	CbGeAlD
Imipramine—Ethopropazine—BCHE—kidney cancer	0.000239	0.0494	CrCbGaD
Imipramine—ABCB1—renal system—kidney cancer	0.000235	0.00442	CbGeAlD
Imipramine—ABCB1—kidney—kidney cancer	0.000227	0.00427	CbGeAlD
Imipramine—ABCB1—cortex of kidney—kidney cancer	0.000221	0.00416	CbGeAlD
Imipramine—ABCB1—gonad—kidney cancer	0.000211	0.00396	CbGeAlD
Imipramine—Clomipramine—GSTP1—kidney cancer	0.0002	0.0414	CrCbGaD
Imipramine—Triflupromazine—BCHE—kidney cancer	0.000196	0.0404	CrCbGaD
Imipramine—Body temperature increased—Dactinomycin—kidney cancer	0.000134	0.000703	CcSEcCtD
Imipramine—Asthenia—Sorafenib—kidney cancer	0.000133	0.0007	CcSEcCtD
Imipramine—Malaise—Paclitaxel—kidney cancer	0.000133	0.000697	CcSEcCtD
Imipramine—Cardiac failure—Doxorubicin—kidney cancer	0.000133	0.000696	CcSEcCtD
Imipramine—Syncope—Paclitaxel—kidney cancer	0.000132	0.000693	CcSEcCtD
Imipramine—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000132	0.000693	CcSEcCtD
Imipramine—Leukopenia—Paclitaxel—kidney cancer	0.000132	0.000692	CcSEcCtD
Imipramine—Decreased appetite—Vincristine—kidney cancer	0.000132	0.00069	CcSEcCtD
Imipramine—Pruritus—Sorafenib—kidney cancer	0.000132	0.00069	CcSEcCtD
Imipramine—Vomiting—Erlotinib—kidney cancer	0.000131	0.00069	CcSEcCtD
Imipramine—Gastrointestinal disorder—Vincristine—kidney cancer	0.000131	0.000686	CcSEcCtD
Imipramine—Fatigue—Vincristine—kidney cancer	0.00013	0.000685	CcSEcCtD
Imipramine—Rash—Erlotinib—kidney cancer	0.00013	0.000684	CcSEcCtD
Imipramine—Dermatitis—Erlotinib—kidney cancer	0.00013	0.000683	CcSEcCtD
Imipramine—Palpitations—Paclitaxel—kidney cancer	0.00013	0.000683	CcSEcCtD
Imipramine—Insomnia—Gemcitabine—kidney cancer	0.00013	0.000681	CcSEcCtD
Imipramine—Eye disorder—Capecitabine—kidney cancer	0.00013	0.000681	CcSEcCtD
Imipramine—Headache—Erlotinib—kidney cancer	0.000129	0.000679	CcSEcCtD
Imipramine—Tinnitus—Capecitabine—kidney cancer	0.000129	0.000679	CcSEcCtD
Imipramine—Loss of consciousness—Paclitaxel—kidney cancer	0.000129	0.000679	CcSEcCtD
Imipramine—Constipation—Vincristine—kidney cancer	0.000129	0.000679	CcSEcCtD
Imipramine—Paraesthesia—Gemcitabine—kidney cancer	0.000129	0.000676	CcSEcCtD
Imipramine—Flushing—Capecitabine—kidney cancer	0.000129	0.000676	CcSEcCtD
Imipramine—Cardiac disorder—Capecitabine—kidney cancer	0.000129	0.000676	CcSEcCtD
Imipramine—Asthenia—Sunitinib—kidney cancer	0.000128	0.000674	CcSEcCtD
Imipramine—Nausea—Vinblastine—kidney cancer	0.000128	0.00067	CcSEcCtD
Imipramine—Somnolence—Gemcitabine—kidney cancer	0.000128	0.00067	CcSEcCtD
Imipramine—Convulsion—Paclitaxel—kidney cancer	0.000128	0.00067	CcSEcCtD
Imipramine—Affect lability—Doxorubicin—kidney cancer	0.000127	0.000668	CcSEcCtD
Imipramine—Nausea—Everolimus—kidney cancer	0.000127	0.000668	CcSEcCtD
Imipramine—Diarrhoea—Sorafenib—kidney cancer	0.000127	0.000668	CcSEcCtD
Imipramine—Hypertension—Paclitaxel—kidney cancer	0.000127	0.000667	CcSEcCtD
Imipramine—Pruritus—Sunitinib—kidney cancer	0.000127	0.000664	CcSEcCtD
Imipramine—Angiopathy—Capecitabine—kidney cancer	0.000126	0.000661	CcSEcCtD
Imipramine—Immune system disorder—Capecitabine—kidney cancer	0.000125	0.000658	CcSEcCtD
Imipramine—Mediastinal disorder—Capecitabine—kidney cancer	0.000125	0.000657	CcSEcCtD
Imipramine—Anxiety—Paclitaxel—kidney cancer	0.000125	0.000656	CcSEcCtD
Imipramine—Decreased appetite—Gemcitabine—kidney cancer	0.000125	0.000655	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000124	0.000653	CcSEcCtD
Imipramine—Arrhythmia—Capecitabine—kidney cancer	0.000124	0.000651	CcSEcCtD
Imipramine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000124	0.00065	CcSEcCtD
Imipramine—Discomfort—Paclitaxel—kidney cancer	0.000124	0.00065	CcSEcCtD
Imipramine—Fatigue—Gemcitabine—kidney cancer	0.000124	0.000649	CcSEcCtD
Imipramine—Gastrointestinal pain—Vincristine—kidney cancer	0.000124	0.000649	CcSEcCtD
Imipramine—Dizziness—Sorafenib—kidney cancer	0.000123	0.000645	CcSEcCtD
Imipramine—Constipation—Gemcitabine—kidney cancer	0.000123	0.000644	CcSEcCtD
Imipramine—Nausea—Erlotinib—kidney cancer	0.000123	0.000644	CcSEcCtD
Imipramine—Alopecia—Capecitabine—kidney cancer	0.000123	0.000644	CcSEcCtD
Imipramine—Dry mouth—Paclitaxel—kidney cancer	0.000123	0.000643	CcSEcCtD
Imipramine—Mood swings—Doxorubicin—kidney cancer	0.000123	0.000643	CcSEcCtD
Imipramine—Diarrhoea—Sunitinib—kidney cancer	0.000122	0.000642	CcSEcCtD
Imipramine—Ataxia—Doxorubicin—kidney cancer	0.000122	0.000638	CcSEcCtD
Imipramine—Mental disorder—Capecitabine—kidney cancer	0.000122	0.000638	CcSEcCtD
Imipramine—Asthenia—Dactinomycin—kidney cancer	0.000121	0.000638	CcSEcCtD
Imipramine—Confusional state—Paclitaxel—kidney cancer	0.000121	0.000636	CcSEcCtD
Imipramine—Malnutrition—Capecitabine—kidney cancer	0.000121	0.000634	CcSEcCtD
Imipramine—Anaphylactic shock—Paclitaxel—kidney cancer	0.00012	0.000631	CcSEcCtD
Imipramine—Oedema—Paclitaxel—kidney cancer	0.00012	0.000631	CcSEcCtD
Imipramine—Body temperature increased—Vincristine—kidney cancer	0.00012	0.000628	CcSEcCtD
Imipramine—Abdominal pain—Vincristine—kidney cancer	0.00012	0.000628	CcSEcCtD
Imipramine—Liver function test abnormal—Doxorubicin—kidney cancer	0.000119	0.000627	CcSEcCtD
Imipramine—Infection—Paclitaxel—kidney cancer	0.000119	0.000627	CcSEcCtD
Imipramine—Dysgeusia—Capecitabine—kidney cancer	0.000118	0.000621	CcSEcCtD
Imipramine—Dizziness—Sunitinib—kidney cancer	0.000118	0.000621	CcSEcCtD
Imipramine—Feeling abnormal—Gemcitabine—kidney cancer	0.000118	0.000621	CcSEcCtD
Imipramine—Shock—Paclitaxel—kidney cancer	0.000118	0.00062	CcSEcCtD
Imipramine—Vomiting—Sorafenib—kidney cancer	0.000118	0.00062	CcSEcCtD
Imipramine—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000118	0.00062	CcSEcCtD
Imipramine—Nervous system disorder—Paclitaxel—kidney cancer	0.000118	0.000618	CcSEcCtD
Imipramine—Thrombocytopenia—Paclitaxel—kidney cancer	0.000118	0.000617	CcSEcCtD
Imipramine—Tachycardia—Paclitaxel—kidney cancer	0.000117	0.000616	CcSEcCtD
Imipramine—Rash—Sorafenib—kidney cancer	0.000117	0.000615	CcSEcCtD
Imipramine—Dermatitis—Sorafenib—kidney cancer	0.000117	0.000615	CcSEcCtD
Imipramine—Breast disorder—Doxorubicin—kidney cancer	0.000117	0.000613	CcSEcCtD
Imipramine—Skin disorder—Paclitaxel—kidney cancer	0.000117	0.000613	CcSEcCtD
Imipramine—Headache—Sorafenib—kidney cancer	0.000116	0.000611	CcSEcCtD
Imipramine—Hyperhidrosis—Paclitaxel—kidney cancer	0.000116	0.00061	CcSEcCtD
Imipramine—Diarrhoea—Dactinomycin—kidney cancer	0.000116	0.000608	CcSEcCtD
Imipramine—Anorexia—Paclitaxel—kidney cancer	0.000115	0.000601	CcSEcCtD
Imipramine—Vision blurred—Capecitabine—kidney cancer	0.000114	0.000598	CcSEcCtD
Imipramine—Vomiting—Sunitinib—kidney cancer	0.000114	0.000597	CcSEcCtD
Imipramine—Body temperature increased—Gemcitabine—kidney cancer	0.000113	0.000595	CcSEcCtD
Imipramine—Tremor—Capecitabine—kidney cancer	0.000113	0.000594	CcSEcCtD
Imipramine—Rash—Sunitinib—kidney cancer	0.000113	0.000592	CcSEcCtD
Imipramine—Dermatitis—Sunitinib—kidney cancer	0.000113	0.000591	CcSEcCtD
Imipramine—Ill-defined disorder—Capecitabine—kidney cancer	0.000112	0.000588	CcSEcCtD
Imipramine—Headache—Sunitinib—kidney cancer	0.000112	0.000588	CcSEcCtD
Imipramine—Eosinophilia—Doxorubicin—kidney cancer	0.000111	0.000581	CcSEcCtD
Imipramine—Nausea—Sorafenib—kidney cancer	0.00011	0.00058	CcSEcCtD
Imipramine—Malaise—Capecitabine—kidney cancer	0.000109	0.000572	CcSEcCtD
Imipramine—Insomnia—Paclitaxel—kidney cancer	0.000109	0.00057	CcSEcCtD
Imipramine—Asthenia—Vincristine—kidney cancer	0.000109	0.00057	CcSEcCtD
Imipramine—Syncope—Capecitabine—kidney cancer	0.000108	0.000569	CcSEcCtD
Imipramine—Nortriptyline—PTGS1—kidney cancer	0.000108	0.0224	CrCbGaD
Imipramine—Leukopenia—Capecitabine—kidney cancer	0.000108	0.000568	CcSEcCtD
Imipramine—Paraesthesia—Paclitaxel—kidney cancer	0.000108	0.000566	CcSEcCtD
Imipramine—Vomiting—Dactinomycin—kidney cancer	0.000108	0.000565	CcSEcCtD
Imipramine—Somnolence—Paclitaxel—kidney cancer	0.000107	0.000561	CcSEcCtD
Imipramine—Palpitations—Capecitabine—kidney cancer	0.000107	0.00056	CcSEcCtD
Imipramine—Rash—Dactinomycin—kidney cancer	0.000107	0.00056	CcSEcCtD
Imipramine—Nausea—Sunitinib—kidney cancer	0.000106	0.000558	CcSEcCtD
Imipramine—Loss of consciousness—Capecitabine—kidney cancer	0.000106	0.000557	CcSEcCtD
Imipramine—Pancytopenia—Doxorubicin—kidney cancer	0.000106	0.000557	CcSEcCtD
Imipramine—Dyspepsia—Paclitaxel—kidney cancer	0.000106	0.000555	CcSEcCtD
Imipramine—Decreased appetite—Paclitaxel—kidney cancer	0.000104	0.000548	CcSEcCtD
Imipramine—Hypertension—Capecitabine—kidney cancer	0.000104	0.000548	CcSEcCtD
Imipramine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000104	0.000544	CcSEcCtD
Imipramine—Fatigue—Paclitaxel—kidney cancer	0.000104	0.000544	CcSEcCtD
Imipramine—Diarrhoea—Vincristine—kidney cancer	0.000104	0.000543	CcSEcCtD
Imipramine—Pollakiuria—Doxorubicin—kidney cancer	0.000103	0.000542	CcSEcCtD
Imipramine—Asthenia—Gemcitabine—kidney cancer	0.000103	0.00054	CcSEcCtD
Imipramine—Constipation—Paclitaxel—kidney cancer	0.000103	0.000539	CcSEcCtD
Imipramine—Anxiety—Capecitabine—kidney cancer	0.000103	0.000538	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000102	0.000536	CcSEcCtD
Imipramine—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000102	0.000535	CcSEcCtD
Imipramine—Epinastine—ABCB1—kidney cancer	0.000102	0.021	CrCbGaD
Imipramine—Weight increased—Doxorubicin—kidney cancer	0.000102	0.000534	CcSEcCtD
Imipramine—Discomfort—Capecitabine—kidney cancer	0.000102	0.000533	CcSEcCtD
Imipramine—Pruritus—Gemcitabine—kidney cancer	0.000102	0.000533	CcSEcCtD
Imipramine—Weight decreased—Doxorubicin—kidney cancer	0.000101	0.000531	CcSEcCtD
Imipramine—Dry mouth—Capecitabine—kidney cancer	0.000101	0.000528	CcSEcCtD
Imipramine—Nausea—Dactinomycin—kidney cancer	0.000101	0.000528	CcSEcCtD
Imipramine—Diphenhydramine—PTGS1—kidney cancer	0.0001	0.0207	CrCbGaD
Imipramine—Dizziness—Vincristine—kidney cancer	0.0001	0.000525	CcSEcCtD
Imipramine—Infestation—Doxorubicin—kidney cancer	9.97e-05	0.000523	CcSEcCtD
Imipramine—Drowsiness—Doxorubicin—kidney cancer	9.97e-05	0.000523	CcSEcCtD
Imipramine—Infestation NOS—Doxorubicin—kidney cancer	9.97e-05	0.000523	CcSEcCtD
Imipramine—Confusional state—Capecitabine—kidney cancer	9.94e-05	0.000522	CcSEcCtD
Imipramine—Feeling abnormal—Paclitaxel—kidney cancer	9.9e-05	0.00052	CcSEcCtD
Imipramine—Oedema—Capecitabine—kidney cancer	9.86e-05	0.000518	CcSEcCtD
Imipramine—Gastrointestinal pain—Paclitaxel—kidney cancer	9.83e-05	0.000516	CcSEcCtD
Imipramine—Diarrhoea—Gemcitabine—kidney cancer	9.82e-05	0.000515	CcSEcCtD
Imipramine—Infection—Capecitabine—kidney cancer	9.8e-05	0.000514	CcSEcCtD
Imipramine—Neuropathy peripheral—Doxorubicin—kidney cancer	9.77e-05	0.000513	CcSEcCtD
Imipramine—Stomatitis—Doxorubicin—kidney cancer	9.71e-05	0.00051	CcSEcCtD
Imipramine—Jaundice—Doxorubicin—kidney cancer	9.71e-05	0.00051	CcSEcCtD
Imipramine—Shock—Capecitabine—kidney cancer	9.7e-05	0.000509	CcSEcCtD
Imipramine—Nervous system disorder—Capecitabine—kidney cancer	9.67e-05	0.000508	CcSEcCtD
Imipramine—Thrombocytopenia—Capecitabine—kidney cancer	9.66e-05	0.000507	CcSEcCtD
Imipramine—Tachycardia—Capecitabine—kidney cancer	9.62e-05	0.000505	CcSEcCtD
Imipramine—Vomiting—Vincristine—kidney cancer	9.62e-05	0.000505	CcSEcCtD
Imipramine—Skin disorder—Capecitabine—kidney cancer	9.58e-05	0.000503	CcSEcCtD
Imipramine—Urticaria—Paclitaxel—kidney cancer	9.55e-05	0.000501	CcSEcCtD
Imipramine—Rash—Vincristine—kidney cancer	9.54e-05	0.000501	CcSEcCtD
Imipramine—Hyperhidrosis—Capecitabine—kidney cancer	9.53e-05	0.0005	CcSEcCtD
Imipramine—Dermatitis—Vincristine—kidney cancer	9.53e-05	0.0005	CcSEcCtD
Imipramine—Abdominal pain—Paclitaxel—kidney cancer	9.5e-05	0.000499	CcSEcCtD
Imipramine—Body temperature increased—Paclitaxel—kidney cancer	9.5e-05	0.000499	CcSEcCtD
Imipramine—Headache—Vincristine—kidney cancer	9.48e-05	0.000497	CcSEcCtD
Imipramine—Chlorpromazine—BCHE—kidney cancer	9.43e-05	0.0195	CrCbGaD
Imipramine—Hepatobiliary disease—Doxorubicin—kidney cancer	9.43e-05	0.000495	CcSEcCtD
Imipramine—Anorexia—Capecitabine—kidney cancer	9.4e-05	0.000493	CcSEcCtD
Imipramine—Agranulocytosis—Doxorubicin—kidney cancer	9.3e-05	0.000488	CcSEcCtD
Imipramine—Vomiting—Gemcitabine—kidney cancer	9.13e-05	0.000479	CcSEcCtD
Imipramine—Rash—Gemcitabine—kidney cancer	9.05e-05	0.000475	CcSEcCtD
Imipramine—Dermatitis—Gemcitabine—kidney cancer	9.04e-05	0.000475	CcSEcCtD
Imipramine—Headache—Gemcitabine—kidney cancer	8.99e-05	0.000472	CcSEcCtD
Imipramine—Nausea—Vincristine—kidney cancer	8.99e-05	0.000472	CcSEcCtD
Imipramine—Hepatitis—Doxorubicin—kidney cancer	8.95e-05	0.00047	CcSEcCtD
Imipramine—Insomnia—Capecitabine—kidney cancer	8.92e-05	0.000468	CcSEcCtD
Imipramine—Hypoaesthesia—Doxorubicin—kidney cancer	8.9e-05	0.000467	CcSEcCtD
Imipramine—Paraesthesia—Capecitabine—kidney cancer	8.85e-05	0.000465	CcSEcCtD
Imipramine—Urinary tract disorder—Doxorubicin—kidney cancer	8.84e-05	0.000464	CcSEcCtD
Imipramine—Urethral disorder—Doxorubicin—kidney cancer	8.77e-05	0.00046	CcSEcCtD
Imipramine—Maprotiline—ABCB1—kidney cancer	8.77e-05	0.0181	CrCbGaD
Imipramine—Dyspepsia—Capecitabine—kidney cancer	8.68e-05	0.000456	CcSEcCtD
Imipramine—Asthenia—Paclitaxel—kidney cancer	8.62e-05	0.000452	CcSEcCtD
Imipramine—Decreased appetite—Capecitabine—kidney cancer	8.57e-05	0.00045	CcSEcCtD
Imipramine—Nausea—Gemcitabine—kidney cancer	8.53e-05	0.000447	CcSEcCtD
Imipramine—Gastrointestinal disorder—Capecitabine—kidney cancer	8.51e-05	0.000447	CcSEcCtD
Imipramine—Fatigue—Capecitabine—kidney cancer	8.5e-05	0.000446	CcSEcCtD
Imipramine—Pruritus—Paclitaxel—kidney cancer	8.5e-05	0.000446	CcSEcCtD
Imipramine—Constipation—Capecitabine—kidney cancer	8.43e-05	0.000443	CcSEcCtD
Imipramine—Eye disorder—Doxorubicin—kidney cancer	8.36e-05	0.000439	CcSEcCtD
Imipramine—Tinnitus—Doxorubicin—kidney cancer	8.34e-05	0.000438	CcSEcCtD
Imipramine—Flushing—Doxorubicin—kidney cancer	8.3e-05	0.000436	CcSEcCtD
Imipramine—Cardiac disorder—Doxorubicin—kidney cancer	8.3e-05	0.000436	CcSEcCtD
Imipramine—Diarrhoea—Paclitaxel—kidney cancer	8.22e-05	0.000432	CcSEcCtD
Imipramine—Feeling abnormal—Capecitabine—kidney cancer	8.13e-05	0.000426	CcSEcCtD
Imipramine—Angiopathy—Doxorubicin—kidney cancer	8.12e-05	0.000426	CcSEcCtD
Imipramine—Immune system disorder—Doxorubicin—kidney cancer	8.08e-05	0.000424	CcSEcCtD
Imipramine—Gastrointestinal pain—Capecitabine—kidney cancer	8.06e-05	0.000423	CcSEcCtD
Imipramine—Mediastinal disorder—Doxorubicin—kidney cancer	8.06e-05	0.000423	CcSEcCtD
Imipramine—Arrhythmia—Doxorubicin—kidney cancer	7.99e-05	0.000419	CcSEcCtD
Imipramine—Dizziness—Paclitaxel—kidney cancer	7.95e-05	0.000417	CcSEcCtD
Imipramine—Alopecia—Doxorubicin—kidney cancer	7.91e-05	0.000415	CcSEcCtD
Imipramine—Mental disorder—Doxorubicin—kidney cancer	7.84e-05	0.000411	CcSEcCtD
Imipramine—Urticaria—Capecitabine—kidney cancer	7.83e-05	0.000411	CcSEcCtD
Imipramine—Body temperature increased—Capecitabine—kidney cancer	7.8e-05	0.000409	CcSEcCtD
Imipramine—Abdominal pain—Capecitabine—kidney cancer	7.8e-05	0.000409	CcSEcCtD
Imipramine—Malnutrition—Doxorubicin—kidney cancer	7.79e-05	0.000409	CcSEcCtD
Imipramine—Triflupromazine—ABCB1—kidney cancer	7.66e-05	0.0158	CrCbGaD
Imipramine—Tension—Doxorubicin—kidney cancer	7.64e-05	0.000401	CcSEcCtD
Imipramine—Vomiting—Paclitaxel—kidney cancer	7.64e-05	0.000401	CcSEcCtD
Imipramine—Dysgeusia—Doxorubicin—kidney cancer	7.63e-05	0.0004	CcSEcCtD
Imipramine—Rash—Paclitaxel—kidney cancer	7.58e-05	0.000398	CcSEcCtD
Imipramine—Dermatitis—Paclitaxel—kidney cancer	7.57e-05	0.000397	CcSEcCtD
Imipramine—Nervousness—Doxorubicin—kidney cancer	7.56e-05	0.000397	CcSEcCtD
Imipramine—Headache—Paclitaxel—kidney cancer	7.53e-05	0.000395	CcSEcCtD
Imipramine—Vision blurred—Doxorubicin—kidney cancer	7.34e-05	0.000385	CcSEcCtD
Imipramine—Ill-defined disorder—Doxorubicin—kidney cancer	7.23e-05	0.000379	CcSEcCtD
Imipramine—Agitation—Doxorubicin—kidney cancer	7.16e-05	0.000376	CcSEcCtD
Imipramine—Nausea—Paclitaxel—kidney cancer	7.14e-05	0.000375	CcSEcCtD
Imipramine—Asthenia—Capecitabine—kidney cancer	7.08e-05	0.000371	CcSEcCtD
Imipramine—Malaise—Doxorubicin—kidney cancer	7.02e-05	0.000369	CcSEcCtD
Imipramine—Syncope—Doxorubicin—kidney cancer	6.98e-05	0.000367	CcSEcCtD
Imipramine—Pruritus—Capecitabine—kidney cancer	6.98e-05	0.000366	CcSEcCtD
Imipramine—Leukopenia—Doxorubicin—kidney cancer	6.97e-05	0.000366	CcSEcCtD
Imipramine—Palpitations—Doxorubicin—kidney cancer	6.88e-05	0.000361	CcSEcCtD
Imipramine—Loss of consciousness—Doxorubicin—kidney cancer	6.85e-05	0.000359	CcSEcCtD
Imipramine—Convulsion—Doxorubicin—kidney cancer	6.75e-05	0.000354	CcSEcCtD
Imipramine—Diarrhoea—Capecitabine—kidney cancer	6.75e-05	0.000354	CcSEcCtD
Imipramine—Hypertension—Doxorubicin—kidney cancer	6.72e-05	0.000353	CcSEcCtD
Imipramine—Anxiety—Doxorubicin—kidney cancer	6.61e-05	0.000347	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	6.59e-05	0.000346	CcSEcCtD
Imipramine—Discomfort—Doxorubicin—kidney cancer	6.55e-05	0.000344	CcSEcCtD
Imipramine—Dizziness—Capecitabine—kidney cancer	6.52e-05	0.000342	CcSEcCtD
Imipramine—Dry mouth—Doxorubicin—kidney cancer	6.49e-05	0.00034	CcSEcCtD
Imipramine—Confusional state—Doxorubicin—kidney cancer	6.41e-05	0.000336	CcSEcCtD
Imipramine—Carbamazepine—ABCB1—kidney cancer	6.39e-05	0.0132	CrCbGaD
Imipramine—Oedema—Doxorubicin—kidney cancer	6.36e-05	0.000334	CcSEcCtD
Imipramine—Anaphylactic shock—Doxorubicin—kidney cancer	6.36e-05	0.000334	CcSEcCtD
Imipramine—Infection—Doxorubicin—kidney cancer	6.32e-05	0.000331	CcSEcCtD
Imipramine—Vomiting—Capecitabine—kidney cancer	6.27e-05	0.000329	CcSEcCtD
Imipramine—Shock—Doxorubicin—kidney cancer	6.25e-05	0.000328	CcSEcCtD
Imipramine—Nervous system disorder—Doxorubicin—kidney cancer	6.23e-05	0.000327	CcSEcCtD
Imipramine—Thrombocytopenia—Doxorubicin—kidney cancer	6.22e-05	0.000327	CcSEcCtD
Imipramine—Rash—Capecitabine—kidney cancer	6.22e-05	0.000326	CcSEcCtD
Imipramine—Dermatitis—Capecitabine—kidney cancer	6.21e-05	0.000326	CcSEcCtD
Imipramine—Tachycardia—Doxorubicin—kidney cancer	6.2e-05	0.000326	CcSEcCtD
Imipramine—Headache—Capecitabine—kidney cancer	6.18e-05	0.000324	CcSEcCtD
Imipramine—Skin disorder—Doxorubicin—kidney cancer	6.17e-05	0.000324	CcSEcCtD
Imipramine—Hyperhidrosis—Doxorubicin—kidney cancer	6.15e-05	0.000323	CcSEcCtD
Imipramine—Anorexia—Doxorubicin—kidney cancer	6.06e-05	0.000318	CcSEcCtD
Imipramine—Nausea—Capecitabine—kidney cancer	5.86e-05	0.000307	CcSEcCtD
Imipramine—Insomnia—Doxorubicin—kidney cancer	5.75e-05	0.000302	CcSEcCtD
Imipramine—Paraesthesia—Doxorubicin—kidney cancer	5.71e-05	0.0003	CcSEcCtD
Imipramine—Somnolence—Doxorubicin—kidney cancer	5.65e-05	0.000297	CcSEcCtD
Imipramine—Dyspepsia—Doxorubicin—kidney cancer	5.6e-05	0.000294	CcSEcCtD
Imipramine—Decreased appetite—Doxorubicin—kidney cancer	5.53e-05	0.00029	CcSEcCtD
Imipramine—Gastrointestinal disorder—Doxorubicin—kidney cancer	5.49e-05	0.000288	CcSEcCtD
Imipramine—Fatigue—Doxorubicin—kidney cancer	5.48e-05	0.000288	CcSEcCtD
Imipramine—Constipation—Doxorubicin—kidney cancer	5.44e-05	0.000285	CcSEcCtD
Imipramine—Clomipramine—ABCB1—kidney cancer	5.39e-05	0.0111	CrCbGaD
Imipramine—Feeling abnormal—Doxorubicin—kidney cancer	5.24e-05	0.000275	CcSEcCtD
Imipramine—Gastrointestinal pain—Doxorubicin—kidney cancer	5.2e-05	0.000273	CcSEcCtD
Imipramine—Urticaria—Doxorubicin—kidney cancer	5.05e-05	0.000265	CcSEcCtD
Imipramine—Abdominal pain—Doxorubicin—kidney cancer	5.03e-05	0.000264	CcSEcCtD
Imipramine—Body temperature increased—Doxorubicin—kidney cancer	5.03e-05	0.000264	CcSEcCtD
Imipramine—Trimipramine—ABCB1—kidney cancer	4.96e-05	0.0102	CrCbGaD
Imipramine—Promethazine—ABCB1—kidney cancer	4.77e-05	0.00987	CrCbGaD
Imipramine—Doxepin—ABCB1—kidney cancer	4.73e-05	0.00977	CrCbGaD
Imipramine—Asthenia—Doxorubicin—kidney cancer	4.56e-05	0.000239	CcSEcCtD
Imipramine—Pruritus—Doxorubicin—kidney cancer	4.5e-05	0.000236	CcSEcCtD
Imipramine—Diarrhoea—Doxorubicin—kidney cancer	4.35e-05	0.000228	CcSEcCtD
Imipramine—Desipramine—ABCB1—kidney cancer	4.34e-05	0.00896	CrCbGaD
Imipramine—Dizziness—Doxorubicin—kidney cancer	4.2e-05	0.000221	CcSEcCtD
Imipramine—Vomiting—Doxorubicin—kidney cancer	4.04e-05	0.000212	CcSEcCtD
Imipramine—Rash—Doxorubicin—kidney cancer	4.01e-05	0.00021	CcSEcCtD
Imipramine—Dermatitis—Doxorubicin—kidney cancer	4e-05	0.00021	CcSEcCtD
Imipramine—Headache—Doxorubicin—kidney cancer	3.98e-05	0.000209	CcSEcCtD
Imipramine—Nausea—Doxorubicin—kidney cancer	3.78e-05	0.000198	CcSEcCtD
Imipramine—Chlorpromazine—ABCB1—kidney cancer	3.7e-05	0.00764	CrCbGaD
Imipramine—Amitriptyline—ABCB1—kidney cancer	3.65e-05	0.00755	CrCbGaD
Imipramine—ADRA1B—Signaling Pathways—RELA—kidney cancer	3.2e-06	4.14e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—KRAS—kidney cancer	3.2e-06	4.14e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—MYC—kidney cancer	3.2e-06	4.14e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—MYC—kidney cancer	3.19e-06	4.14e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—KRAS—kidney cancer	3.19e-06	4.13e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—KRAS—kidney cancer	3.18e-06	4.12e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—ERBB2—kidney cancer	3.18e-06	4.12e-05	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—PIK3CA—kidney cancer	3.18e-06	4.11e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—BCHE—kidney cancer	3.17e-06	4.11e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—KRAS—kidney cancer	3.17e-06	4.11e-05	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—PIK3CA—kidney cancer	3.17e-06	4.1e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—PTEN—kidney cancer	3.16e-06	4.09e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—KRAS—kidney cancer	3.14e-06	4.07e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—VEGFA—kidney cancer	3.14e-06	4.07e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MTOR—kidney cancer	3.14e-06	4.06e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—SLC5A5—kidney cancer	3.13e-06	4.06e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—KRAS—kidney cancer	3.13e-06	4.06e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—MAPK1—kidney cancer	3.13e-06	4.05e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—MAPK1—kidney cancer	3.13e-06	4.05e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—MAPK3—kidney cancer	3.1e-06	4.02e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—ABCB1—kidney cancer	3.1e-06	4.01e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CDKN1B—kidney cancer	3.09e-06	4.01e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CDKN1B—kidney cancer	3.08e-06	3.98e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IL2—kidney cancer	3.03e-06	3.92e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.03e-06	3.92e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—MYC—kidney cancer	3.02e-06	3.91e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IL2—kidney cancer	3.01e-06	3.9e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—GSTM1—kidney cancer	3.01e-06	3.89e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.01e-06	3.89e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—PIK3CA—kidney cancer	2.99e-06	3.87e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—MAPK3—kidney cancer	2.97e-06	3.85e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—RAF1—kidney cancer	2.96e-06	3.84e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—KRAS—kidney cancer	2.96e-06	3.83e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—VEGFA—kidney cancer	2.95e-06	3.82e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—KRAS—kidney cancer	2.95e-06	3.82e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—RELA—kidney cancer	2.95e-06	3.82e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CCND1—kidney cancer	2.95e-06	3.82e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—MAPK1—kidney cancer	2.95e-06	3.82e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CDKN1B—kidney cancer	2.95e-06	3.81e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—JUN—kidney cancer	2.95e-06	3.81e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—PIK3CA—kidney cancer	2.94e-06	3.8e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CCND1—kidney cancer	2.94e-06	3.8e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—ERBB2—kidney cancer	2.93e-06	3.8e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—PIK3CA—kidney cancer	2.93e-06	3.8e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—JUN—kidney cancer	2.93e-06	3.79e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—PIK3CA—kidney cancer	2.92e-06	3.78e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CTNNB1—kidney cancer	2.92e-06	3.78e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—PTEN—kidney cancer	2.92e-06	3.78e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—RAF1—kidney cancer	2.92e-06	3.78e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—PIK3CA—kidney cancer	2.91e-06	3.77e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—RAF1—kidney cancer	2.91e-06	3.77e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CTNNB1—kidney cancer	2.91e-06	3.76e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—RELA—kidney cancer	2.9e-06	3.76e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—RAF1—kidney cancer	2.9e-06	3.76e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—RELA—kidney cancer	2.9e-06	3.75e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MTOR—kidney cancer	2.89e-06	3.75e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—RAF1—kidney cancer	2.89e-06	3.74e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—MYC—kidney cancer	2.89e-06	3.74e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—RELA—kidney cancer	2.89e-06	3.74e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—ERBB2—kidney cancer	2.89e-06	3.74e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—PIK3CA—kidney cancer	2.89e-06	3.74e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IL2—kidney cancer	2.88e-06	3.73e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—ERBB2—kidney cancer	2.88e-06	3.73e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—RELA—kidney cancer	2.88e-06	3.73e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—PTGS2—kidney cancer	2.88e-06	3.73e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—PIK3CA—kidney cancer	2.88e-06	3.73e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—ERBB2—kidney cancer	2.87e-06	3.72e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—RAF1—kidney cancer	2.86e-06	3.71e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—ERBB2—kidney cancer	2.86e-06	3.7e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—RAF1—kidney cancer	2.86e-06	3.7e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—RELA—kidney cancer	2.85e-06	3.69e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CYP1A1—kidney cancer	2.85e-06	3.69e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—PTEN—kidney cancer	2.85e-06	3.69e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MTOR—kidney cancer	2.85e-06	3.69e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—RELA—kidney cancer	2.84e-06	3.68e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MTOR—kidney cancer	2.84e-06	3.68e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—PTEN—kidney cancer	2.83e-06	3.67e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—ERBB2—kidney cancer	2.83e-06	3.67e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MTOR—kidney cancer	2.83e-06	3.67e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—MAPK1—kidney cancer	2.83e-06	3.66e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—ERBB2—kidney cancer	2.83e-06	3.66e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MTOR—kidney cancer	2.82e-06	3.66e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PTGS2—kidney cancer	2.82e-06	3.65e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CCND1—kidney cancer	2.81e-06	3.64e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—JUN—kidney cancer	2.81e-06	3.63e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MTOR—kidney cancer	2.8e-06	3.62e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—MAPK3—kidney cancer	2.79e-06	3.62e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MTOR—kidney cancer	2.79e-06	3.61e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—KRAS—kidney cancer	2.79e-06	3.61e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CTNNB1—kidney cancer	2.78e-06	3.6e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—POMC—kidney cancer	2.73e-06	3.53e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—MYC—kidney cancer	2.72e-06	3.52e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CDKN1B—kidney cancer	2.72e-06	3.52e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—PIK3CA—kidney cancer	2.72e-06	3.51e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—PTEN—kidney cancer	2.71e-06	3.51e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—PIK3CA—kidney cancer	2.71e-06	3.51e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CDKN1B—kidney cancer	2.67e-06	3.46e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—KRAS—kidney cancer	2.67e-06	3.46e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CDKN1B—kidney cancer	2.67e-06	3.45e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—POMC—kidney cancer	2.66e-06	3.45e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CDKN1B—kidney cancer	2.66e-06	3.44e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IL2—kidney cancer	2.66e-06	3.44e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—MAPK1—kidney cancer	2.66e-06	3.44e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CDKN1B—kidney cancer	2.65e-06	3.43e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—TP53—kidney cancer	2.63e-06	3.4e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CDKN1B—kidney cancer	2.62e-06	3.4e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—TP53—kidney cancer	2.62e-06	3.4e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CDKN1B—kidney cancer	2.62e-06	3.39e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IL2—kidney cancer	2.62e-06	3.39e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IL2—kidney cancer	2.61e-06	3.38e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IL2—kidney cancer	2.6e-06	3.37e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IL2—kidney cancer	2.59e-06	3.36e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CCND1—kidney cancer	2.59e-06	3.35e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—JUN—kidney cancer	2.59e-06	3.35e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—VEGFA—kidney cancer	2.57e-06	3.33e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IL2—kidney cancer	2.57e-06	3.32e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CTNNB1—kidney cancer	2.57e-06	3.32e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IL2—kidney cancer	2.56e-06	3.32e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—PIK3CA—kidney cancer	2.56e-06	3.32e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—VEGFA—kidney cancer	2.56e-06	3.31e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CCND1—kidney cancer	2.55e-06	3.3e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—JUN—kidney cancer	2.54e-06	3.29e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CCND1—kidney cancer	2.54e-06	3.29e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—JUN—kidney cancer	2.54e-06	3.29e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CCND1—kidney cancer	2.54e-06	3.28e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—JUN—kidney cancer	2.53e-06	3.28e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CCND1—kidney cancer	2.53e-06	3.27e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CTNNB1—kidney cancer	2.53e-06	3.27e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GSTP1—kidney cancer	2.53e-06	3.27e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—JUN—kidney cancer	2.52e-06	3.27e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CTNNB1—kidney cancer	2.52e-06	3.26e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CTNNB1—kidney cancer	2.51e-06	3.25e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—PTEN—kidney cancer	2.51e-06	3.25e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—KRAS—kidney cancer	2.51e-06	3.25e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—POMC—kidney cancer	2.51e-06	3.25e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CTNNB1—kidney cancer	2.5e-06	3.24e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CCND1—kidney cancer	2.5e-06	3.24e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—PTEN—kidney cancer	2.5e-06	3.24e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—JUN—kidney cancer	2.5e-06	3.23e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CCND1—kidney cancer	2.5e-06	3.23e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—JUN—kidney cancer	2.49e-06	3.23e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CTNNB1—kidney cancer	2.48e-06	3.21e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TP53—kidney cancer	2.48e-06	3.21e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CTNNB1—kidney cancer	2.47e-06	3.2e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—PTEN—kidney cancer	2.46e-06	3.19e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PTEN—kidney cancer	2.46e-06	3.18e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—PTEN—kidney cancer	2.46e-06	3.18e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—PIK3CA—kidney cancer	2.45e-06	3.18e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—VEGFA—kidney cancer	2.45e-06	3.17e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—PTEN—kidney cancer	2.45e-06	3.17e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—PTEN—kidney cancer	2.44e-06	3.16e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MAPK3—kidney cancer	2.43e-06	3.15e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MAPK3—kidney cancer	2.42e-06	3.13e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—PTEN—kidney cancer	2.42e-06	3.13e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—PTEN—kidney cancer	2.41e-06	3.12e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—PIK3CA—kidney cancer	2.39e-06	3.1e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—PIK3CA—kidney cancer	2.39e-06	3.1e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ABCB1—kidney cancer	2.39e-06	3.09e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TP53—kidney cancer	2.37e-06	3.07e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MYC—kidney cancer	2.37e-06	3.06e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MYC—kidney cancer	2.36e-06	3.05e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.34e-06	3.03e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GSTM1—kidney cancer	2.32e-06	3e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MAPK3—kidney cancer	2.32e-06	3e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MAPK1—kidney cancer	2.32e-06	3e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—PIK3CA—kidney cancer	2.31e-06	2.99e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MAPK1—kidney cancer	2.3e-06	2.98e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—VEGFA—kidney cancer	2.26e-06	2.92e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MYC—kidney cancer	2.25e-06	2.92e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TP53—kidney cancer	2.23e-06	2.89e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—PIK3CA—kidney cancer	2.23e-06	2.89e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—VEGFA—kidney cancer	2.22e-06	2.88e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—VEGFA—kidney cancer	2.22e-06	2.87e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—VEGFA—kidney cancer	2.21e-06	2.86e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MAPK1—kidney cancer	2.21e-06	2.86e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—VEGFA—kidney cancer	2.2e-06	2.85e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.2e-06	2.85e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—KRAS—kidney cancer	2.19e-06	2.83e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—VEGFA—kidney cancer	2.18e-06	2.83e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—VEGFA—kidney cancer	2.18e-06	2.82e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—KRAS—kidney cancer	2.18e-06	2.82e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PTGS2—kidney cancer	2.18e-06	2.82e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MAPK3—kidney cancer	2.14e-06	2.77e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—POMC—kidney cancer	2.13e-06	2.75e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PTGS2—kidney cancer	2.12e-06	2.75e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MAPK3—kidney cancer	2.1e-06	2.72e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MAPK3—kidney cancer	2.1e-06	2.72e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MAPK3—kidney cancer	2.09e-06	2.71e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MAPK3—kidney cancer	2.09e-06	2.7e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—KRAS—kidney cancer	2.08e-06	2.7e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MYC—kidney cancer	2.08e-06	2.69e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MAPK3—kidney cancer	2.06e-06	2.67e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MAPK3—kidney cancer	2.06e-06	2.67e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—PIK3CA—kidney cancer	2.06e-06	2.67e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MYC—kidney cancer	2.05e-06	2.65e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MYC—kidney cancer	2.04e-06	2.64e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MYC—kidney cancer	2.03e-06	2.63e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MAPK1—kidney cancer	2.03e-06	2.63e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MYC—kidney cancer	2.03e-06	2.63e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—PIK3CA—kidney cancer	2.01e-06	2.6e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MYC—kidney cancer	2.01e-06	2.6e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MYC—kidney cancer	2e-06	2.59e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MAPK1—kidney cancer	2e-06	2.59e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PTGS2—kidney cancer	2e-06	2.59e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—PIK3CA—kidney cancer	2e-06	2.59e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MAPK1—kidney cancer	2e-06	2.58e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MAPK1—kidney cancer	1.99e-06	2.58e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MAPK1—kidney cancer	1.98e-06	2.57e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MAPK1—kidney cancer	1.96e-06	2.54e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MAPK1—kidney cancer	1.96e-06	2.54e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TP53—kidney cancer	1.94e-06	2.52e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TP53—kidney cancer	1.93e-06	2.5e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—KRAS—kidney cancer	1.92e-06	2.49e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—PIK3CA—kidney cancer	1.91e-06	2.48e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PTEN—kidney cancer	1.9e-06	2.46e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—KRAS—kidney cancer	1.89e-06	2.45e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—KRAS—kidney cancer	1.89e-06	2.44e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—KRAS—kidney cancer	1.88e-06	2.43e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—KRAS—kidney cancer	1.87e-06	2.43e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—KRAS—kidney cancer	1.86e-06	2.4e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PTEN—kidney cancer	1.85e-06	2.4e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TP53—kidney cancer	1.85e-06	2.4e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—KRAS—kidney cancer	1.85e-06	2.4e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—PIK3CA—kidney cancer	1.77e-06	2.29e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—PIK3CA—kidney cancer	1.76e-06	2.28e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PTEN—kidney cancer	1.74e-06	2.26e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—PIK3CA—kidney cancer	1.74e-06	2.25e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PIK3CA—kidney cancer	1.73e-06	2.25e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—PIK3CA—kidney cancer	1.73e-06	2.24e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—PIK3CA—kidney cancer	1.73e-06	2.24e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—PIK3CA—kidney cancer	1.72e-06	2.23e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TP53—kidney cancer	1.71e-06	2.21e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—PIK3CA—kidney cancer	1.7e-06	2.21e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—PIK3CA—kidney cancer	1.7e-06	2.2e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PTGS2—kidney cancer	1.7e-06	2.19e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TP53—kidney cancer	1.68e-06	2.17e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TP53—kidney cancer	1.68e-06	2.17e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TP53—kidney cancer	1.67e-06	2.16e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TP53—kidney cancer	1.67e-06	2.16e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TP53—kidney cancer	1.65e-06	2.13e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TP53—kidney cancer	1.64e-06	2.13e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—POMC—kidney cancer	1.64e-06	2.12e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PTEN—kidney cancer	1.48e-06	1.91e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.34e-06	1.73e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PTGS2—kidney cancer	1.31e-06	1.69e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PIK3CA—kidney cancer	1.31e-06	1.69e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.23e-06	1.59e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PTEN—kidney cancer	1.14e-06	1.48e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.04e-06	1.35e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PIK3CA—kidney cancer	8.05e-07	1.04e-05	CbGpPWpGaD
